Systematic Review

Published on 26 Sep 2023

Effectiveness and safety of pelareorep plus chemotherapy versus chemotherapy alone for advanced solid tumors: a meta-analysis

in Drugs Outcomes Research and Policies

Renxian Xie
Hongxin Huang
Tong Chen
Xuehan Huang
Chuangzhen Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1228225

2,473 views

Original Research

Published on 20 Sep 2023

Validation of the Arabic version of the general medication adherence scale in patients with type 2 diabetes mellitus in Jordan

in Drugs Outcomes Research and Policies

Md. Ashraful Islam
Faris El-Dahiyat
Ahmed Nouri
Qais Alefan
Atta Abbas Naqvi

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1194672

2,446 views

Perspective

Published on 20 Sep 2023

Evaluating treatments in rare indications warrants a Bayesian approach

in Drugs Outcomes Research and Policies

Emma K. Mackay
Aaron Springford

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1249611

1,630 views
1 citation

Original Research

Published on 18 Sep 2023

The international clinical trials registry platform (ICTRP): data integrity and the trends in clinical trials, diseases, and drugs

in Drugs Outcomes Research and Policies

Eugenia D. Namiot
Diana Smirnovová
Aleksandr V. Sokolov
Vladimir N. Chubarev
Vadim V. Tarasov
Helgi B. Schiöth

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1228148

5,911 views
5 citations

Hypothesis and Theory

Published on 15 Sep 2023

Approach to machine learning for extraction of real-world data variables from electronic health records

in Drugs Outcomes Research and Policies

Blythe Adamson
Michael Waskom
Auriane Blarre
Jonathan Kelly
Konstantin Krismer
Sheila Nemeth
James Gippetti
John Ritten
Katherine Harrison
George Ho

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1180962

7,521 views
19 citations

Original Research

Published on 13 Sep 2023

Acceptance rate of clinical pharmacists’ recommendations—an ongoing journey for integration

in Drugs Outcomes Research and Policies

Orit Peled
Yael Vitzrabin
Eran Beit Ner
Moran Lazaryan
Maya Berlin
Dana Barchel
Matitiahu Berkovitch
Yiftah Beer
Eran Tamir

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1253990

2,117 views
3 citations

Original Research

Published on 13 Sep 2023

SGLT2 inhibitors for patients with heart failure with preserved ejection fraction in China: a cost-effectiveness study

in Drugs Outcomes Research and Policies

He Lu
Pingping Shang
Dexing Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1155210

1,916 views
1 citation

Systematic Review

Published on 11 Sep 2023

Comparison of the efficacy and safety of different doses of atropine for myopic control in children: a meta-analysis

in Drugs Outcomes Research and Policies

Peixian Hou
Dawen Wu
Yan Nie
Hong Wei
Longqian Liu
Guoyuan Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1227787

3,861 views
2 citations

Methods

Published on 11 Sep 2023

A change point-based analysis procedure for improving the success rate of decision-making in clinical trials with delayed treatment effects

in Drugs Outcomes Research and Policies

Long-Shen Xie
Hui Lu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1186456

1,154 views
2 citations

Systematic Review

Published on 07 Sep 2023

Effectiveness of decision support tools on reducing antibiotic use for respiratory tract infections: a systematic review and meta-analysis

in Drugs Outcomes Research and Policies

Rixiang Xu
Lang Wu
Lingyun Wu
Caiming Xu
Tingyu Mu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1253520

2,395 views
2 citations

Original Research

Published on 07 Sep 2023

The participation of clinical pharmacists in the treatment of patients with central nervous system infection can improve the effectiveness and appropriateness of anti-infective treatments: a retrospective cohort study

in Drugs Outcomes Research and Policies

Jie Cheng
ChuanDong Dang
Xiao Li
JianJun Wang
Xin Huang
Yan Li
XueYan Cui

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1226333

1,934 views
2 citations

Original Research

Published on 07 Sep 2023

Cost-effectiveness analysis of transarterial chemoembolization combined with lenvatinib as the first-line treatment for advanced hepatocellular carcinoma

in Drugs Outcomes Research and Policies

Ying He
Wangchun Lin
Zhongjie Cai
Yufan Huang
Maojin You
Meisheng Lei
Ruijia Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1219694

1,679 views
3 citations

Original Research

Published on 05 Sep 2023

A quasi-experimental study of the volume-based procurement (VBP) effect on antiviral medications of hepatitis B virus in China

in Drugs Outcomes Research and Policies

Xiaotong Wen
Luxinyi Xu
Xiaoze Chen
Ruonan Wu
Jia Luo
Yuying Wan
Zongfu Mao

Frontiers in Pharmacology

doi 10.3389/fphar.2023.984794

2,144 views

Original Research

Published on 05 Sep 2023

Community pharmacists’ perspectives on cardiovascular disease pharmaceutical care in the United Arab Emirates: a questionnaire survey-based analysis

in Drugs Outcomes Research and Policies

Ammar Abdulrahman Jairoun
Sabaa Saleh Al-Himyari
Moyad Shahwan
Mina Al Ani
Mustafa Habeb
Maimona Jairoun
Sa’ed H. Zyoud
Mustfa Faisal Alkhanani
Reem Hasaballah Alhasani
Alqassem Y. Hakami

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1237717

6,320 views
2 citations

Systematic Review

Published on 01 Sep 2023

Comparative effect of antihypertensive drugs in improving arterial stiffness in adults with hypertension (RIGIPREV study). A network meta-analysis

in Drugs Outcomes Research and Policies

Iván Cavero-Redondo
Alicia Saz-Lara
Cristina Lugones-Sánchez
Diana P. Pozuelo-Carrascosa
Leticia Gómez-Sánchez
José Francisco López-Gil
Luis García-Ortiz
Rosa Maria Bruno
Manuel Ángel Gómez-Marcos

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1225795

2,738 views
8 citations

Clinical Trial

Published on 01 Sep 2023

Intraoperative slow-release dexamethasone intravitreal implant (Ozurdex) in epiretinal membrane peeling surgery: a prospective randomized controlled trial

in Drugs Outcomes Research and Policies

Siying Li
Qiaozhu Zeng
Li Zhu
Wenbo Liu
Yujing Li
Jiarui Li
Xiaoxin Li
Mingwei Zhao
Jinfeng Qu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1219861

1,635 views

Navigation group

Articles

Effectiveness and safety of pelareorep plus chemotherapy versus chemotherapy alone for advanced solid tumors: a meta-analysis

Validation of the Arabic version of the general medication adherence scale in patients with type 2 diabetes mellitus in Jordan

Evaluating treatments in rare indications warrants a Bayesian approach

The international clinical trials registry platform (ICTRP): data integrity and the trends in clinical trials, diseases, and drugs

Approach to machine learning for extraction of real-world data variables from electronic health records

Acceptance rate of clinical pharmacists’ recommendations—an ongoing journey for integration

SGLT2 inhibitors for patients with heart failure with preserved ejection fraction in China: a cost-effectiveness study

Comparison of the efficacy and safety of different doses of atropine for myopic control in children: a meta-analysis

A change point-based analysis procedure for improving the success rate of decision-making in clinical trials with delayed treatment effects

Effectiveness of decision support tools on reducing antibiotic use for respiratory tract infections: a systematic review and meta-analysis

The participation of clinical pharmacists in the treatment of patients with central nervous system infection can improve the effectiveness and appropriateness of anti-infective treatments: a retrospective cohort study

Cost-effectiveness analysis of transarterial chemoembolization combined with lenvatinib as the first-line treatment for advanced hepatocellular carcinoma

A quasi-experimental study of the volume-based procurement (VBP) effect on antiviral medications of hepatitis B virus in China

Community pharmacists’ perspectives on cardiovascular disease pharmaceutical care in the United Arab Emirates: a questionnaire survey-based analysis

Comparative effect of antihypertensive drugs in improving arterial stiffness in adults with hypertension (RIGIPREV study). A network meta-analysis

Intraoperative slow-release dexamethasone intravitreal implant (Ozurdex) in epiretinal membrane peeling surgery: a prospective randomized controlled trial